Enfin, en ce qui concerne la modification de l'offre et les risques de compensation croisée, la Commission a constaté que, bien que l'engagement de ne pas revendre le produit concerné limiterait certains risques de compensation croisée, la question principale, à savoir le PMI appliqué aux transactions entre entités liées, reste posée.
Finally, concerning the amendment of the offer and the risks of cross-compensation, the Commission noted that, whilst the commitment not to re-sell the product concerned would limit some of the cross-compensation risks the principal issue, namely the MIP being applied to transactions between related entities, remains.